BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36382943)

  • 1. Early recruitment of PARP-dependent m
    Legartová S; Svobodová Kovaříková A; Běhalová Suchánková J; Polášek-Sedláčková H; Bártová E
    RNA Biol; 2022 Jan; 19(1):1153-1171. PubMed ID: 36382943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N
    Svobodová Kovaříková A; Stixová L; Kovařík A; Komůrková D; Legartová S; Fagherazzi P; Bártová E
    Cells; 2020 Feb; 9(2):. PubMed ID: 32033081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PARP-dependent and NAT10-independent acetylation of N4-cytidine in RNA appears in UV-damaged chromatin.
    Svobodová Kovaříková A; Stixová L; Kovařík A; Bártová E
    Epigenetics Chromatin; 2023 Jun; 16(1):26. PubMed ID: 37322549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Base excision repair defects invoke hypersensitivity to PARP inhibition.
    Horton JK; Stefanick DF; Prasad R; Gassman NR; Kedar PS; Wilson SH
    Mol Cancer Res; 2014 Aug; 12(8):1128-39. PubMed ID: 24770870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p21CDKN1A participates in base excision repair by regulating the activity of poly(ADP-ribose) polymerase-1.
    Cazzalini O; Donà F; Savio M; Tillhon M; Maccario C; Perucca P; Stivala LA; Scovassi AI; Prosperi E
    DNA Repair (Amst); 2010 Jun; 9(6):627-35. PubMed ID: 20303835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XRCC1 counteracts poly(ADP ribose)polymerase (PARP) poisons, olaparib and talazoparib, and a clinical alkylating agent, temozolomide, by promoting the removal of trapped PARP1 from broken DNA.
    Hirota K; Ooka M; Shimizu N; Yamada K; Tsuda M; Ibrahim MA; Yamada S; Sasanuma H; Masutani M; Takeda S
    Genes Cells; 2022 May; 27(5):331-344. PubMed ID: 35194903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olaparib enhances curcumin-mediated apoptosis in oral cancer cells by inducing PARP trapping through modulation of BER and chromatin assembly.
    Molla S; Chatterjee S; Sethy C; Sinha S; Kundu CN
    DNA Repair (Amst); 2021 Sep; 105():103157. PubMed ID: 34144488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing oxidation of cellular XRCC1 affects PARP-mediated DNA damage responses.
    Horton JK; Stefanick DF; Gassman NR; Williams JG; Gabel SA; Cuneo MJ; Prasad R; Kedar PS; Derose EF; Hou EW; London RE; Wilson SH
    DNA Repair (Amst); 2013 Sep; 12(9):774-85. PubMed ID: 23871146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Base excision repair proteins are required for integrin-mediated suppression of bleomycin-induced DNA breakage in murine lung endothelial cells.
    Rose JL; Reeves KC; Likhotvorik RI; Hoyt DG
    J Pharmacol Exp Ther; 2007 Apr; 321(1):318-26. PubMed ID: 17202402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARP inhibition versus PARP-1 silencing: different outcomes in terms of single-strand break repair and radiation susceptibility.
    Godon C; Cordelières FP; Biard D; Giocanti N; Mégnin-Chanet F; Hall J; Favaudon V
    Nucleic Acids Res; 2008 Aug; 36(13):4454-64. PubMed ID: 18603595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly (ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate.
    Ström CE; Johansson F; Uhlén M; Szigyarto CA; Erixon K; Helleday T
    Nucleic Acids Res; 2011 Apr; 39(8):3166-75. PubMed ID: 21183466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PARP inhibitor Olaparib disrupts base excision repair of 5-aza-2'-deoxycytidine lesions.
    Orta ML; Höglund A; Calderón-Montaño JM; Domínguez I; Burgos-Morón E; Visnes T; Pastor N; Ström C; López-lázaro M; Helleday T
    Nucleic Acids Res; 2014 Aug; 42(14):9108-20. PubMed ID: 25074383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p21CDKN1A Regulates the Binding of Poly(ADP-Ribose) Polymerase-1 to DNA Repair Intermediates.
    Dutto I; Sukhanova M; Tillhon M; Cazzalini O; Stivala LA; Scovassi AI; Lavrik O; Prosperi E
    PLoS One; 2016; 11(1):e0146031. PubMed ID: 26730949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress in sperm affects the epigenetic reprogramming in early embryonic development.
    Wyck S; Herrera C; Requena CE; Bittner L; Hajkova P; Bollwein H; Santoro R
    Epigenetics Chromatin; 2018 Oct; 11(1):60. PubMed ID: 30333056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcription-coupled DNA repair-initiating protein CSB promotes XRCC1 recruitment to oxidative DNA damage.
    Menoni H; Wienholz F; Theil AF; Janssens RC; Lans H; Campalans A; Radicella JP; Marteijn JA; Vermeulen W
    Nucleic Acids Res; 2018 Sep; 46(15):7747-7756. PubMed ID: 29955842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruitment of KMT2C/MLL3 to DNA Damage Sites Mediates DNA Damage Responses and Regulates PARP Inhibitor Sensitivity in Cancer.
    Chang A; Liu L; Ashby JM; Wu D; Chen Y; O'Neill SS; Huang S; Wang J; Wang G; Cheng D; Tan X; Petty WJ; Pasche BC; Xiang R; Zhang W; Sun P
    Cancer Res; 2021 Jun; 81(12):3358-3373. PubMed ID: 33853832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XRCC1 prevents toxic PARP1 trapping during DNA base excision repair.
    Demin AA; Hirota K; Tsuda M; Adamowicz M; Hailstone R; Brazina J; Gittens W; Kalasova I; Shao Z; Zha S; Sasanuma H; Hanzlikova H; Takeda S; Caldecott KW
    Mol Cell; 2021 Jul; 81(14):3018-3030.e5. PubMed ID: 34102106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TET-mediated DNA hydroxymethylation is negatively influenced by the PARP-dependent PARylation.
    Tolić A; Ravichandran M; Rajić J; Đorđević M; Đorđević M; Dinić S; Grdović N; Jovanović JA; Mihailović M; Nestorović N; Jurkowski TP; Uskoković AS; Vidaković MS
    Epigenetics Chromatin; 2022 Apr; 15(1):11. PubMed ID: 35382873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An insight into understanding the coupling between homologous recombination mediated DNA repair and chromatin remodeling mechanisms in plant genome: an update.
    Banerjee S; Roy S
    Cell Cycle; 2021 Sep; 20(18):1760-1784. PubMed ID: 34437813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N
    Fukumoto T; Zhu H; Nacarelli T; Karakashev S; Fatkhutdinov N; Wu S; Liu P; Kossenkov AV; Showe LC; Jean S; Zhang L; Zhang R
    Cancer Res; 2019 Jun; 79(11):2812-2820. PubMed ID: 30967398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.